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Abstract Tissue engineering of heart valves investigates the
possibility to create a fully compatible and biomimetic graft
able to provide host cell repopulation like the native living
valve. Decellularized aortic and pulmonary valves and syn-
thetic polymers have been used to promote the creation of a
native-like scaffold suitable to be colonized by cells either
in vitro, in dynamic bioreactors or in vivo using different
animal models. The herein presented research provides the
intra-operative protocol and details of surgical technique. Por-
cine aortic valve conduits were decellularized and implanted in
the right ventricular outflow tract of Vietnamese pigs.
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Video Description
All animal experiments and surgical procedures were performed
in compliance with standards ISO 10993-1, 10993-2 and UNI
EN ISO 5840. Aortic valve conduits were isolated from young
common breeding piglets (3–4 months old), decellularized
according to TRICOL protocol [1, 2] and were implanted in
the right ventricular outflow tract (RVOT) of Vietnamese pigs
(VPs) using cardiopulmonary bypass.
The extracorporeal circulation (ECC) circuit was coupled
with a paediatric oxygenator (Sorin Dideco D902 Lilliput 2),
certified to provide blood flow up to 2,300 cc min−1 (100-cc
filling volumes) which worked very well till 4,500 cc min−1
with maximal oxygen supply to the oxygenating chamber.
VPs diuresis was stimulated with 18 % mannitol infusion in
the ECC prime and with furosemide at an initial dosage of 1
to 2 mg kg−1. The pump was a first-generation Stöckert HLM
(Stöckert Instrumente, Schmitten, Germany). The prime for-
mula and ECC weaning used were prepared as shown in
Table 1.
The surgery began with a xypho-jugular incision followed
by median longitudinal sternotomy and pericardiotomy.
Screening of the total systemic ACT heparinization (ACT
values >400 s) was determined as well. In order to activate
the ECC, two Ticron 2-0 purse string sutures were trimmed
on the ascending aorta, both internally and externally, even-
tually reinforced with pledgets. A paediatric aortic cannula
(10–14 Fr, Medronic, Hopkinton, MA) was then inserted in
the supra-aortic position, and the drainage of the cardiac
chambers was performed with a double-vein cannulation
for the superior and inferior venae cavae. Once all tubes
were connected to the ECC circuit, the normothermic extra-
corporeal circulation (2.6 L min−1 m−1) was turned on along
with the ventilation suspension.
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The native pulmonary artery root was then removed from
the beating heart, paying particular attention to avoiding
damages to the coronary artery branches. The RVOT was
then reconstructed using the decellularized aortic root with
the coronary ostia trimmed and ligated [3, 4] (Fig. 1). With
the procedure completed, the VP was weaned from ECC with
restoration of mechanic lung ventilation. At the end, a
retrosternal mediastinal drainage was positioned together with
a pleural drainage.
After surgery, the animals were then weaned from the
ventilator and allowed to breathe spontaneously. Post-
operative anticoagulation therapy was maintained, providing
the animals, two times daily, with 100 mg of lysine acetyl-
salicylate administered IV. Antibiotic therapy (cefazolin 25-
mg kg−1 bid) was also infused for 10 days after surgery to
avoid endocarditis.
This translational research provides a complete meth-
odological information for implantation of a tissue-
engineered heart valve and animal handling during sur-
gery and over the early post-operative time. Surgical
feasibility has been demonstrated, and future studies have
been initiated to assess long-term in vivo functionality
as well as cell repopulation according to in vivo tissue-
guided regeneration paradigm.
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Fig. 1 Implantation of the prepared aortic decellularized root (coronary
ostia trimmed)
Table 1 Prime and ECC weaning formula
Prime Quantity
Whole blood 500/600 cc
Electrolytic solution 50 cc
Sodium bicarbonate 10 mEq
Heparin 2,000 U.I.
Mannitol, 18 % 3 cc/kg
Furosemide 2 mg (0.2 cc)
Magnesium 2 g (20 cc)
Potassium 4 mEq (2 cc)
ECC weaning
Magnesium 2 g (20 cc)
Potassium 5 mEq/L
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